The Study of Tamoxifen and Raloxifene: Preliminary Enrollment Data from a Randomized Breast Cancer Risk Reduction Trial
- 1 June 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3 (2) , 153-159
- https://doi.org/10.3816/cbc.2002.n.020
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer IncidenceJNCI Journal of the National Cancer Institute, 1999
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitmentCancer, 1995
- Long-Term Risk of Breast Cancer in Women with FibroadenomaNew England Journal of Medicine, 1994
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985